- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2-HER3 dimer
Total 3283 results
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Yale UniversityGenentech, Inc.CompletedHer2-Positive Breast CancerUnited States
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingNon-small Cell Lung CancerChina
-
Samsung Medical CenterRecruitingBreast CancerKorea, Republic of
-
Prof. W. JanniActive, not recruitingHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-squamous NSCLC | HER2 Exon 20 MutationKorea, Republic of, United States, Taiwan, Belgium, Spain, China, Australia, Turkey, Italy, France, Germany, Poland, Russian Federation
-
Spectrum Pharmaceuticals, IncTerminatedNSCLCUnited States, Canada, Netherlands, Belgium, Israel, Spain, France, Italy
-
Nancy Lin, MDGlaxoSmithKline; NovartisActive, not recruitingBreast CancerUnited States
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Gilead SciencesCompletedHER2 Negative Breast Carcinoma Expressing CEAFrance
-
AgendiaCompleted
-
Alteogen, Inc.Cristália Produtos Químicos Farmacêuticos Ltda.Completed
-
Baylor Breast Care CenterAstraZenecaTerminated
-
Fudan UniversityUnknown
-
AIO-Studien-gGmbHRoche Pharma AGCompletedAdenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the StomachGermany
-
Youzhi ZhuRecruitingBreast Cancer FemaleChina
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedMalignant Neoplasm of BreastUnited States
-
Jungsil RoPfizer; HK inno.N CorporationCompletedBreast CancerKorea, Republic of
-
Jungsil RoCompletedBreast CancerKorea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...Zhejiang Cancer HospitalRecruiting
-
Yonsei UniversityNot yet recruiting
-
Zydus Lifesciences LimitedNot yet recruiting
-
iOMEDICO AGSeagen Inc.RecruitingHER2-positive Breast CancerGermany, Austria
-
Lucia Del Mastro,MDCompleted
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Huashan HospitalRecruitingHER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Fudan UniversityNot yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingHER2-positive Breast Cancer
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Hunan Cancer HospitalRecruiting
-
German Breast GroupRoche Pharma AGRecruitingHER2-positive Breast CancerGermany
-
Xijing HospitalNot yet recruitingBreast Cancer | HER2-positive Breast Cancer
-
Breast Cancer Trials, Australia and New ZealandRecruitingBreast Cancer | HER2-positive Breast CancerAustralia
-
University of UtahRecruitingHER2-negative Breast CancerUnited States
-
Fudan UniversityRecruitingHER2-positive Breast CancerChina
-
Genor Biopharma Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHER2-positive Breast CancerChina
-
Centre Jean PerrinRecruitingHER2 Positive Breast CancerFrance
-
Shanghai Henlius BiotechActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast CancerChina
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
University of Kansas Medical CenterTerminatedHER2-positive Breast CancerUnited States
-
University of RochesterSuspendedHER2-positive Breast CancerUnited States
-
Armando GiulianoWithdrawnBreast Cancer | HER2-positive Breast CancerUnited States